GlassScriptPhysician profile
Antony Anandaraj
NPI 1811429178
$4,915.23
in general payments reported to CMS, 2019-2025
19 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.65 · 2021: $682 · 2022: $888 · 2023: $734 · 2024: $2,172 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,809 · Travel and Lodging: $1,377 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.44 |
| Travel and Lodging | $1,377.49 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,070.84 | 2022-2024 | Glidewire, R2p Misago, Tr Band |
| Abbott Laboratories | $915.82 | 2021-2025 | Cardiomems, Diamondback Coronary, Pressurewire |
| Medtronic, INC. | $661.39 | 2024 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $534.38 | 2020-2024 | Brilinta, Farxiga |
| Abiomed | $521.98 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $396.51 | 2020-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $144.54 | 2021-2022 | |
| Philips North America LLC | $128.50 | 2022-2024 | (Br3) Coronary Other |
| Lantheus Medical Imaging, INC. | $102.62 | 2021-2022 | |
| Getinge USA Sales, LLC | $88.81 | 2022-2023 | Cardiohelp |
| Atricure, INC. | $77.09 | 2022 | |
| Teleflex LLC | $65.16 | 2023 | Trapliner |
| Shockwave Medical, INC | $51.97 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $50.29 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $33.87 | 2023-2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23.11 | 2025 | Farapulse |
| Edwards Lifesciences Corporation | $20.94 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $15.43 | 2025 | |
| Irhythm Technologies, INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antony Anandaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.